RecruitingNot ApplicableNCT07022990

Improving Medication Management in World Trade Center Responders

Promoting Healthy Aging Among WTC Responders: Frailty Trajectories And Intervention Strategies

Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

50 participants

Start Date

Apr 8, 2025

Study Type

INTERVENTIONAL

Conditions

Polypharmacy

Summary

By 2030, the majority of World Trade Center (WTC) rescue and recovery workers (responders) will be aged 65 and over and at risk for aging-related conditions and consequences including the concurrent use of five or more medications (i.e., polypharmacy). The purpose of this research study is to investigate an educational approach targeting polypharmacy through de-prescribing unnecessary and burdensome medications via the support of informed discussions between WTC responders and their prescribing physicians.

Eligibility

Min Age: 50 Years

Inclusion Criteria8

A WTC responder already enrolled in the "Promoting Healthy Aging Among WTC Responders: Frailty Trajectories and Intervention Strategies" study cohort
aged 50 years or older, and
taking one of the five medication classes:
proton pump inhibitors (PPIs),
benzodiazepine (BZs) and
non-benzodiazepine sedative hypnotics ("Z-drugs"),
first-generation antihistamines (FGA), and
skeletal muscle relaxants (SMR).

Exclusion Criteria1

None

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREducational brochure for deprescribing

Study participant will be provided information (i.e., educational brochure) about one of the five medication classes participants may be taking that are known to have potential side effects for older adults: proton pump inhibitors (PPIs), benzodiazepine (BZs) and non-benzodiazepine sedative hypnotics ("Z-drugs"), first-generation antihistamines (FGA), and skeletal muscle relaxants (SMR) to determine their necessity.